C2N Diagnostics lands $10m cash injection from Samsung
C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said the…
News
Vave Health launches Universal Wireless Probe for full-body imaging
Helius joins BCI landscape with new subsidiary
Roche Diagnostics supports UK eye cancer AI initiative
University of Turku develops carbon nanotube sensors for health monitoring
FDA approves early feasibility study of Valcare’s transcatheter device
Vivani treats first patient with long-lasting drug implant for weight loss
FDA clears Perfuze’s Zipline access catheter for stroke treatment
